Fractyl Health, Inc.

Fractyl Health, Inc. (GUTS) priced its initial public offering on Feb 2, 2024 at $15.00 per share, within its $14.00–$16.00 range, raising $110M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $714.1M. BofA Securities was lead-left underwriter, joined by Morgan Stanley and Evercore ISI. Latham & Watkins advised the company and Goodwin Procter advised the underwriters.

Fractyl Health, Inc. is a metabolic therapeutics company pioneering new approaches to treating metabolic diseases, including type 2 diabetes and obesity, which it describes as rapidly growing drivers of illness and death.

Status

IPO

Ticker

GUTS

Exchange

Nasdaq Global Market

Priced

Feb 2, 2024

IPO price

$15.00

Price range

$14.00–$16.00

Raised

$110M

Market cap at IPO price

$714.1M

First filed

Dec 14, 2023

Underwriters

BofA Securities, Morgan Stanley and Evercore ISI

Company counsel

Latham & Watkins

Underwriters' counsel

Goodwin Procter

Sector

Healthcare

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.